The aim of this study was twofold: first to assess the prognostic value of CD57+ tumor infiltrating lymphocytes (TILs) in head and neck tumors; and second to investigate the reproducibility of these analyses using QuPath digital image analysis. This evidence concerns the gene B3GAT1 and neoplasm.